Homebiotech

biotech

biotech

Kither Biotech completes phase 1 trial of inhaled peptide therapy for respiratory diseases

Jim Cornall - June 22, 2026

biotech

Houdini Bio launches to solve therapeutic and commercial genetic medicine bottlenecks

Jim Cornall - June 22, 2026

biotech

Base to Base biotech podcast 64: Solving logistics challenges

Jim Cornall - June 19, 2026

biotech

Preclinical results for novel therapeutic candidate for rare neurodevelopmental disorders

Jim Cornall - June 18, 2026

biotech

Video: Lithuanian company Caszyme at forefront of gene editing

Jim Cornall - November 14, 2023

biotech

Kuano raises £1.8M to accelerate quantum drug discovery

Jim Cornall - September 14, 2023

biotech

Intellegens and CPI receive grant to advance manufacture of oligonucleotide therapeutics with machine learning

Jim Cornall - August 31, 2023

biotech

10 Lithuanian startups to watch

Jim Cornall - July 30, 2023

biotech

Revolutionary self-sensing electric artificial muscles

Jim Cornall - July 18, 2023

biotech

Using DNA for data storage

Jim Cornall - July 18, 2023

1...82 8384Page 84 of 84

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Kither Biotech completes phase 1 trial of inhaled peptide therapy for respiratory diseases

Jim Cornall - June 22, 2026 0

Kither Biotech Pty Ltd and Kither Biotech srl have announced the successful completion of their phase 1 clinical study of KIT2014 in healthy participants. KIT2014...

Houdini Bio launches to solve therapeutic and commercial genetic medicine bottlenecks

biotech Jim Cornall - June 22, 2026 0

Base to Base biotech podcast 64: Solving logistics challenges

biotech Jim Cornall - June 19, 2026 0

Preclinical results for novel therapeutic candidate for rare neurodevelopmental disorders

biotech Jim Cornall - June 18, 2026 0

Breakthrough in personalised treatments for lung cancer

biotech Jim Cornall - June 18, 2026 0